Meditop Pharmaceutical Co. Ltd.

What Meditop Pharmaceutical Co. Ltd. does

Meditop Pharmaceutical Co. Ltd. (MEDITOP Gyógyszeripari Kft.) is a privately held, 100% Hungarian-owned pharmaceutical manufacturer founded in 1991 and headquartered in Pilisborosjenő, Hungary. The company operates a single-site GMP-compliant manufacturing facility producing solid dosage pharmaceutical forms — tablets, film-coated tablets, hard capsules, granules, and pellets — and runs a portfolio spanning nine proprietary OTC brands (including Nodoryl analgesics, Memoril Mite, Intestal, Spaverin, Optacid, Mycosid, Vition, Hyperol, and Betacid) plus five categories of prescription medicines covering CNS, bacterial and viral infections, cardiovascular prevention, and metabolic disorders. Manufacturing is supported by Quality by Design (QbD) development methodology, closed-system fluidisation drying equipment, and continuous film-coating capability with coating cycles of 10–15 minutes. Meditop holds 15 inventions and patent applications, including one granted European patent being validated in 25 countries.

The company operates a hybrid business model with two revenue streams. The first is proprietary pharmaceutical product sales distributed through Hungarian pharmacy retail for OTC products and through healthcare providers for Rx medicines. The second is a B2B contract development and manufacturing organization (CDMO) offering for pharmaceutical partners, covering formulation development, manufacturing technology transfer, clinical-trial and bioequivalence sample production, packaging (including randomized double-blind packaging, serialization, and aggregation), registration and regulatory services across the EU and international markets, and investigational medicinal product manufacturing with QP release. Go-to-market relies on direct healthcare-professional engagement through sponsorship of medical congresses (particularly in neurology and epileptology), continuing-education grants, dedicated product microsites for OTC brands, and CSR-driven brand-building activities. Meditop maintains research relationships with the medical and pharmaceutical faculties of Semmelweis, Debrecen, Szeged, and Pécs universities, and is a member of MAGYOSZ (the Association of Hungarian Pharmaceutical Manufacturers). The leadership comprises co-founders and managing directors Dr. Zoltán Ács and Dr. Dávid Lajos Greskovits, with the next generation of both founding families involved in operations.

Name

Meditop Pharmaceutical Co. Ltd.

Legal name

MEDITOP Pharmaceutical Ltd.

Website

https://meditop.hu

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

Meditop Pharmaceutical Co. Ltd. is a privately held, 100% Hungarian-owned pharmaceutical manufacturer founded in 1991, producing proprietary OTC and Rx solid-dosage medicines in Hungary and offering B2B contract manufacturing, R&D, regulatory, and clinical-trial supply services to pharmaceutical partners across the EU.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Generic pharmaceutical manufacturing
• OTC pharmaceutical products
• Contract manufacturing services
• Prescription drug development
• Pharmaceutical regulatory services

Headquarters

HQ city

Pilisborosjeno

HQ country

Hungary

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of proprietary pharmaceutical products including prescription medicines (Rx) and over-the-counter (OTC) non-prescription products. Product categories include CNS treatments, antibiotics, antivirals, cardiovascular prevention, metabolic disorder treatments, analgesics, antispasmodics, and dermatological products.
2. Contract Manufacturing: Manufacturing of solid dosage forms (granules, powders, pellets, hard capsules, tablets, film-coated tablets) and packaging services for pharmaceutical companies. Includes blistering, cartoning, bagging, counting into bottles/ jars, repackaging, serializing, and aggregating.
3. Registration and Regulatory Services: Development of registration strategies, marketing authorization applications, regulatory approvals in the EU and international markets, life-cycle management documentation, and regulatory communication services.
4. R&D Cooperation: Contract development work for generic, super-generic, and originator products including formulation development, manufacturing technology, clinical trial sample production, bioequivalence testing, and registration documentation. Also includes dietary supplement development.
5. Investigational Medicinal Products: Production and packaging of clinical trial materials including Phase I study samples, multi-agent combination products, with QP release and transport to trial sites.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Meditop Pharmaceutical Co. Ltd. manufactures pharmaceutical products in solid dosage forms (tablets, film-coated tablets, capsules, granules) for both prescription (Rx) and over-the-counter (OTC) markets, with a portfolio spanning CNS treatments, antibiotics, antivirals, cardiovascular prevention, metabolic disorder, analgesic, antispasmodic, and dermatological indications. In parallel, the company offers B2B contract manufacturing, regulatory registration, R&D cooperation, and clinical trial supply services to pharmaceutical partners.

Product overview

Meditop Pharmaceutical Co. Ltd. is a Hungarian pharmaceutical manufacturer offering a portfolio of non-prescription (OTC) and prescription (Rx) medicines across multiple therapeutic areas. The OTC portfolio includes analgesics (Nodoryl Complex, Nodoryl Forte, Nodoryl Dolo), neurological treatments (Memoril Mite), gastrointestinal products (Intestal, Optacid, Betacid), cardiovascular support (Vition), dermatological antifungals (Mycosid), and antiseptics (Hyperol). The Rx portfolio covers five therapeutic categories: Central Nervous System, Bacterial Infections, Viral Infections, Cardiovascular Prevention, and Metabolic Disorders. Additionally, the company provides contract manufacturing services for solid dosage forms, regulatory registration services, R&D cooperation, and clinical trial product manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• Nodoryl: Pain relief product line including Nodoryl Complex, Nodoryl Forte, and Nodoryl Dolo
• Memoril Mite
• Intestal
• Spaverin
• Optacid
• Mycosid
• Vition
• Hyperol
• Betacid

Products and services

• Nodoryl Complex Non-prescription combined analgesic tablets containing methamizole sodium, caffeine and drotaverine hydrochloride for severe headache, headache refractory to other treatments, and the initial phase of mild to moderate migraine attacks. Distributed through Hungarian pharmacies.
• Nodoryl Forte Non-prescription analgesic tablets containing 500mg metamizole sodium for relieving high fever that does not respond to other treatments. Distributed through Hungarian pharmacies.
• Nodoryl Dolo Non-prescription analgesic tablets containing 250mg metamizole sodium for reducing various pain types including headache, toothache, musculoskeletal pain, menstrual pain, and fever. Distributed through Hungarian pharmacies.
• Memoril Mite Non-prescription memory enhancement medicine containing 600mg piracetam film-coated tablets that slows age-related decline in mental abilities, improves mild forgetfulness, and increases motivation. Distributed through Hungarian pharmacies.
• Intestal Over-the-counter preparation containing bismuth subsalicylate for restoring natural balance of intestinal function, effective for diarrhoea, gastric upset, heartburn, and nausea. Distributed through Hungarian pharmacies.
• Spaverin Antispasmodic tablets with drotaverine hydrochloride that relieves smooth muscle spasms of various origins including gastrointestinal, kidney, bile, bladder, and ureter spasms, and as adjunctive treatment for menstrual cramps. Distributed through Hungarian pharmacies.
• Optacid Granules containing sodium dihydrogen phosphate dihydrate and sodium bisulphate for treating symptoms of gastric acidity and anacidity, acid reflux, stomach complaints, and peptic ulcers. Distributed through Hungarian pharmacies.
• Mycosid Anti-fungal medication for external use with constricting and anti-itch effect for prevention and treatment of surface fungal infections of the skin, including athlete's foot and dermatomycosis. Distributed through Hungarian pharmacies.
• Vition Hungarian-developed non-prescription medicine containing potassium, magnesium, zinc and phosphate ions for supplementing diet and supporting heart function, cell regeneration, and adaptation to mental and physical stress. Distributed through Hungarian pharmacies.
• Hyperol Disinfectant containing carbamide peroxide used externally for wound cleaning, skin injury disinfection, acne treatment, oral mucosa treatment, and denture disinfection. Distributed through Hungarian pharmacies.
• Betacid Medicine in granulated powder form combining pepsin and betaine hydrochloride for treating symptoms caused by partial or complete absence of gastric acid. Distributed through Hungarian pharmacies.
• Prescription Medicines (CNS) Prescription medicines for the treatment of central nervous system disorders, distributed to Hungarian healthcare providers, hospitals, and pharmacies.
• Prescription Medicines (Bacterial Infections) Prescription antibiotics and antibacterial medicines for the treatment of bacterial infections, distributed to Hungarian healthcare providers, hospitals, and pharmacies.
• Prescription Medicines (Viral Infection) Prescription preparations for the treatment of viral infections, distributed to Hungarian healthcare providers, hospitals, and pharmacies.
• Prescription Medicines (Cardiovascular) Prescription medicines for the prevention of cardiovascular diseases, distributed to Hungarian healthcare providers, hospitals, and pharmacies.
• Prescription Medicines (Metabolic Disorders) Prescription medicines for the treatment of metabolic disorders, distributed to Hungarian healthcare providers, hospitals, and pharmacies.
• Contract Manufacturing B2B contract manufacturing of solid phase pharmaceutical forms (granules, powders, pellets, hard capsules, tablets, film-coated tablets) and their packaging, including blistering, cartoning, bagging, counting into bottles/jars, repackaging, serializing, and aggregating. Closed system kneading, fluidisation drying, and continuous film coating equipment support the offering.
• Registration and Regulatory Services Development of registration strategies for proprietary medicinal products, registration of contract partners' products, regulatory approvals in the EU and worldwide, life-cycle management documentation, and regulatory communication services spanning the entire product lifecycle.
• Research and Development Cooperation Contract development work for production of generic, super-generic and originator products, including formulation development, manufacturing technology, clinical trial samples, bioequivalence testing, registration documentation preparation, and dietary supplement development.
• Investigational Medicinal Products Manufacture, packaging (including randomized double-blind packaging), and delivery of solid dosage forms for human phase clinical trials and bioequivalence studies, including Phase I study samples and multi-agent combination products with QP release and transport to trial sites.

Quantifiable outcome

• European patent validated in 25 countries
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Ecumenical Relief Organisation (Ökumenikus Segélyszervezet)coreStrategic or Co-development Partner · 1 January 2011MEDITOP Pharmaceutical Ltd. has been a strategic partner of the Ecumenical Relief Organisation since 2011. The partnership involves ongoing support for charitable activities, including donations of medicines and multivitamin supplements, volunteer work, and support for relief programs including Transcarpathia aid. The company also sponsors the organization's annual gathering events.
• Hungarian Scientific UniversitiescoreStrategic or Co-development PartnerMEDITOP has established close research relations with Hungarian scientific universities, specifically the medical and pharmaceutical departments and institutes of Budapest (Semmelweis University), Debrecen, Szeged, and Pécs. These partnerships support the company's R&D activities and drug development programs.
• MAGYOSZ (Association of Hungarian Pharmaceutical Manufacturers)coreStrategic or Co-development PartnerAs a member company of MAGYOSZ, MEDITOP participates in industry self-regulation and has joined the Generic Transparency Code initiative to promote transparency in financial relationships between the pharmaceutical industry and healthcare professionals.
• Dominique Carpenter Event Organizing Ltd.minorStrategic or Co-development PartnerCo-organizer of the annual Carpathian MEDITOP Cup International Women's Handball Tournament, an event that brings together Hungarian communities from across borders through sport.
• Ikarus Athletics BSEminorGTM or Marketing PartnerCommitted supporter of Ikarus Athletics BSE athletes since 2004. The association has 400 athletes training under 19 coaches. Support includes sponsorship of sports activities and events.
• Gézengúz FoundationminorGTM or Marketing PartnerRegular key supporter since April 2023 of the Gézengúz Foundation which provides early childhood intervention care for premature and neurologically damaged children. Support enables the foundation's niche activities to be fully implemented.
• Pilisborosjenő Municipality and Local CommunityminorGTM or Marketing PartnerCommitted supporter of local community initiatives including the B52 JazzFest, Szelávi Festival, and various local cultural and sports events in Pilisborosjenő where the company's headquarters is located.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Recipharm: European CDMO headquartered in Sweden offering solid dose, semi-solid, and sterile manufacturing plus development services. Directly comparable to Meditop's contract manufacturing, formulation development, and registration service offering, though at substantially larger scale.
• Gedeon Richter Plc: Hungary's largest pharmaceutical manufacturer headquartered in Budapest, producing branded generics and specialty pharmaceuticals across CNS, women's health, and cardiovascular. Directly comparable as a Hungarian-based mid/large pharma manufacturer with strong generics and CDMO presence in the EU.
• Aenova Group: European CDMO specializing in solid dosage forms, semi-solids, and sterile products for pharma and consumer health. Directly comparable to Meditop's solid-dose contract manufacturing and packaging services, serving overlapping European generic and OTC customers.
• Egis Pharmaceuticals: Budapest-based pharmaceutical manufacturer (majority-owned by Servier) producing generic and branded medicines across cardiovascular, CNS, and respiratory. Comparable as a Hungarian-headquartered generics manufacturer with overlapping therapeutic categories and EU distribution.

Emerging players

• Alvotech: Iceland-based biosimilars-focused pharmaceutical company with vertically integrated development and manufacturing. Compares as an emerging European pharmaceutical manufacturer with strong technical IP and growing international commercial footprint, though focused on biologics rather than small molecules.

Regional players

• Polpharma Group: Polish pharmaceutical manufacturer producing generics, OTC, and APIs with strong Central/Eastern European footprint. Comparable as a regional generics and OTC manufacturer with overlapping therapeutic categories and contract manufacturing capabilities.
• STADA Arzneimittel AG: German-headquartered European generics and consumer health company with strong presence in Central Europe. Comparable as a European-focused generics and OTC manufacturer competing in similar pharmacy channels and therapeutic categories.
• KRKA, d. d., Novo mesto: Slovenian generic pharmaceutical manufacturer with broad CEE and CIS distribution and significant CDMO capabilities. Comparable as a Central European generics manufacturer with overlapping therapeutic coverage and similar regional positioning to Meditop.

Broad incumbents

• Teva Pharmaceutical Industries: Global generics leader with broad branded and generic portfolios including CNS, pain, and cardiovascular categories that overlap Meditop's therapeutic focus. Broad incumbent competing across European generic and OTC markets.
• Catalent, Inc. Global CDMO offering formulation development, clinical trial supply, and commercial manufacturing across multiple dosage forms. Broad incumbent with significantly larger scale and global footprint, competing for the same CDMO opportunities Meditop targets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/meditop-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meditop Pharmaceutical Co. Ltd.